Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $35.91 USD
Change Today -0.21 / -0.58%
Volume 290.5K
HAE On Other Exchanges
New York
As of 2:19 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brian P. Concannon

Chief Executive Officer, President and Director,Haemonetics Corporation
AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2015


Mr. Brian P. Concannon has been the Chief Executive Officer and President of Haemonetics Corporation since April 2009. Mr. Concannon served as the Chief Operating Officer of Haemacure Corporation. He served as the Chief Operating Officer at Haemonetics Corporation from August 6, 2007 to April 2009 and served as its President of Global Markets from April 2006 to 2007 and Unit President since August 2003. Mr. Concannon served as the President of Patient Division at Haemonetics ...

Read Full Background

Corporate Headquarters*

400 Wood Road
Braintree, Massachusetts 02184

United States

Phone: 781-848-7100
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director
Independent Director, Chairman of Corporate Governance & Nominating Committee, Member of Chief Executive Officer Search Committee and Member of Strategy Committee


BSE 1979
United States Military Academy

Other Affiliations*

Annual Compensation*

Total Annual Compensation$640,192

Stock Options*

Restricted Stock Awards$2,812,457
All Other Compensation$6,900
Exercised Options Value$451,823
Exercisable Options843,734
Exercisable Options Value$11,457,010
Unexercisable Options475,991
Unexercisable Options Value$2,969,903
Total Value of Options$14,878,735
Total Number of Options1,319,725

Total Compensation*

Total Annual Cash Compensation$1,089,872
Total Short Term Compensation$640,192
Other Long Term Compensation$2,819,357
Total Calculated Compensation$4,839,823
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAE:US $35.91 USD -0.21


Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Yutaro Shintaku President and Representative Director
Terumo Corporation
Ulf Mark Schneider Chairman of the Management Board - Fresenius Management Se, Chief Executive Officer of Fresenius Management Se and President of Fresenius Management Se
Fresenius SE & Co KGaA
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAEMONETICS CORP/MASS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at